BTK inhibitor has promising safety and efficacy profiles in relapsed CLL treatment
WEEKLY MOST-READ RANKING
#01Product Highlight - Sovaldi
#02Real vs sham acupuncture: no difference, but still benefits, for hot flashes
#03Poor cardiovascular health predicts cardiovascular disease and cancer risk in minorities and less educated postmenopausal women
#04US FDA approves MSD’s new HCV drug
#05Overcoming challenges in treatment of acid-related disorders
In combination w/ other medicinal products for the treatment of chroni...
Treatment of relapsing remitting multiple sclerosis in adults.